Unlock instant, AI-driven research and patent intelligence for your innovation.

Heterotactic aryl carboxylic acid compound, preparation method thereof, medicine composition comprising compound and application of compound

A technology of biheteroaryl carboxylic acid and aryl carboxylic acid, which is applied in the fields of drug combination, digestive system, organic chemistry, etc.

Active Publication Date: 2012-10-31
SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
View PDF8 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Triglyceride is an energy substance necessary for the human body to maintain normal physiological functions, but excessive accumulation in the body will lead to metabolic diseases such as obesity, insulin resistance, fatty liver and hyperlipidemia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Heterotactic aryl carboxylic acid compound, preparation method thereof, medicine composition comprising compound and application of compound
  • Heterotactic aryl carboxylic acid compound, preparation method thereof, medicine composition comprising compound and application of compound
  • Heterotactic aryl carboxylic acid compound, preparation method thereof, medicine composition comprising compound and application of compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] The preparation of the compound of embodiment 1 general formula 4

[0074] Preparation of Compound 4-1

[0075]

[0076] The raw material compound (5-bromo-2-cyanopyridine) 1.82g, nitrophenylboronic acid pinacol 2.62g (1.2 equivalents), bis(triphenylphosphine) palladium dichloride 0.35g (0.05 equivalents), carbonic acid Cesium 6.52 (2 equivalents) was dissolved in DMF, and the reaction system was changed to an inert gas environment, heated to 70-80°C to react overnight, evaporated to remove DMF, added water to dissolve the inorganic matter, filtered, and drained to obtain compound a (crude product); a is dissolved in 50-60% by volume of sulfuric acid, heated to 130-140°C for 2-3 hours, pouring the reaction solution into ice and using NaOH to adjust the pH value to 2-3, filtering, and draining to obtain compound b (crude product);

[0077]

[0078] Compound b 0.5g obtained from the above reaction, 0.446g (1.5 equivalents) of L-tert-leucyl amino ester, O-(IH-benzot...

Embodiment 2

[0128] The preparation of the compound of embodiment 2 general formula I-1

[0129]Preparation of compound yhhu-2407

[0130]

[0131] Step 1: Dissolve compound 4-1 in anhydrous methanol, add 10wt% palladium carbon in a nitrogen atmosphere, add 3 to 4 equivalents of sodium borohydride under ice bath, react for 5 to 6 hours, the reaction is complete, add 1N hydrochloric acid Until no bubbles emerged, the palladium carbon was filtered off, the solvent was removed by rotary evaporation, water and dichloromethane were added, the organic phase was separated, dried over anhydrous sodium sulfate, the organic solvent was removed by rotary evaporation, and compound 5-1 was obtained by column chromatography;

[0132]

[0133] The second step: dissolve compound 5-1 in dry tetrahydrofuran, add 1.5 equivalents of phenyl isocyanate, add two equivalents of triethylamine, react overnight at room temperature, evaporate the organic solvent, add dichloromethane and water, separate the orga...

Embodiment 3

[0286] The preparation of the compound of embodiment 3 general formula 10

[0287] Preparation of compound 10-1

[0288]

[0289] The first step: raw material compound 5-bromo-2-pyridinecarboxylic acid 1.82g, L-proline methyl ester (1.5 equivalents), TBTU are dissolved in 10ml DMF, add diisopropylethylamine (2 equivalent), react overnight at room temperature, remove DMF by rotary evaporation, add water and dichloromethane, separate the organic layer, dry over anhydrous sodium sulfate, remove the solvent by rotary evaporation, and obtain compound 10-1a separated by column chromatography.

[0290]

[0291] The second step: dissolve compound 10-1a, 4-nitrophenylboronic acid pinacol (1.2 equivalents), tetraphenylphosphine palladium (0.05 equivalents), and potassium carbonate (2 equivalents) in a mixed solvent of toluene-ethanol-water In , the reaction system was changed to an inert gas environment, heated to 70-80° C. to react overnight, the solvent was evaporated, dichloro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a heterotactic aryl carboxylic acid compound as shown in a general formula I, a preparation method of the compound, a medicine composition comprising the compound and application of the compound, in particular to a novel compound synthesized by using heterotactic aryl as a framework and designing different substituent groups, a preparation method of the compound, a medicine composition comprising the compound and application of the compound to preparing medicines for treating obesity, diabetes mellitus, hyperlipidemia, hepatic steatosis and other metabolism-related diseases.

Description

technical field [0001] The invention relates to a biheteroaryl carboxylic acid compound, a preparation method thereof, a pharmaceutical composition containing the compound and use thereof. Specifically, the present invention relates to a novel compound synthesized by designing different substituents with a biheteroaryl group as the skeleton, a preparation method of the compound, a pharmaceutical composition including the compound, and the preparation of the compound Use in medicines for treating or controlling overweight, obesity, diabetes, hyperlipidemia, fatty liver and other metabolic diseases related to DGAT. Background technique [0002] With the improvement of people's material life, obesity, diabetes, and cardiovascular diseases are becoming more and more common, becoming an important threat to human health. Since obesity is one of the major risk factors for cardiovascular disease, the treatment of obesity has aroused great enthusiasm among scientists, resulting in t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D401/06C07D213/81C07D403/06C07D401/12A61K31/506A61K31/444A61K31/4439A61K31/4418A61P3/04A61P3/10A61P3/06A61P1/16
Inventor 胡有洪王贺瑶闫建伟姬俊盛佳王婷
Owner SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI